RANDALL HENDERSON: Open Payments
NPI 1700879848 · WHITNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,447 in 72 payments from 20 companies in 2025. Trend: 2023 $1,761 · 2024 $1,653 · 2025 $1,447
Food & beverage: $1,447
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 9 | $218 |
| Axsome Therapeutics, Inc. | 10 | $193 |
| AstraZeneca Pharmaceuticals LP | 7 | $173 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $147 |
| Supernus Pharmaceuticals, Inc. | 2 | $112 |
| HARMONY BIOSCIENCES LLC | 3 | $94 |
| Lilly USA, LLC | 4 | $72 |
| Exact Sciences Corporation | 4 | $71 |
| Amgen Inc. | 4 | $64 |
| Verona Pharma, Inc. | 2 | $49 |
Products named: TRELEGY ELLIPTA, Auvelity, JARDIANCE, Qelbree, WAKIX, AIRSUPRA, MOUNJARO, BREZTRI.
Industry payments across TX — which companies pay providers there.
